115 filings
Page 5 of 6
8-K
u01h0
28 Jan 21
Departure of Directors or Certain Officers
4:46pm
424B4
zex1qqu8ojwmbjf iyh3
7 Jan 21
Prospectus supplement with pricing info
4:11pm
EFFECT
demfy5lddcxf9 xpy5w
7 Jan 21
Notice of effectiveness
12:15am
S-1MEF
jj3nn
6 Jan 21
Registration of additional securities for an S-1
8:48pm
8-K
5r7e710dc
4 Jan 21
Results of Operations and Financial Condition
4:19pm
CORRESP
n1ut1tgrr akp4w
4 Jan 21
Correspondence with SEC
12:00am
CORRESP
be0p4js
4 Jan 21
Correspondence with SEC
12:00am
UPLOAD
0barjipc9ddsye6y0
23 Dec 20
Letter from SEC
12:00am
DRS
czo7 htfx06
21 Dec 20
Draft registration statement
12:00am
10-Q
083e9yoqzyf wt
10 Nov 20
Quarterly report
8:00am
8-K
vlrwdr
10 Nov 20
Prelude Therapeutics Announces Third Quarter 2020 Financial Results
7:37am
8-K
68mm3 xocslqjkw
4 Nov 20
Entry into a Material Definitive Agreement
4:09pm
424B4
e8b7oup b6waj2
25 Sep 20
Prospectus supplement with pricing info
4:08pm
EFFECT
4og11e6k9wxtkk4x0d8
25 Sep 20
Notice of effectiveness
12:15am
S-8
x50mjxjvqgc81br5 7xk
25 Sep 20
Registration of securities for employees
12:00am
CERT
xacmus6mzp39zu
24 Sep 20
Certification of approval for exchange listing
10:01am
CORRESP
0g0m6sjnnojbf1 u6
22 Sep 20
Correspondence with SEC
12:00am
CORRESP
ibpes kthllg3hpblote
22 Sep 20
Correspondence with SEC
12:00am